Mark Shackleton

15PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersTumour immunologyGene and molecular therapyAuditing and accountabilityMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jan 05, 2026
Incidence of Reported Pseudoprogression on <sup>18</sup>F-FDG PET/CT in Metastatic Melanoma Patients Undergoing Immune Checkpoint Inhibitor Immunotherapy.

Philip Macilwraith, Mark Shackleton, Andrew Haydon

|Dec 09, 2025
Genomic copy number burden distinguishes the diagnosis and prognosis of primary dermal melanoma.

Peinan Zhao, Christopher Chew, Pacman Szeto

|Jun 30, 2025
Prospective Isolation According to Melanin Pigment Content of Melanoma Cells With Heterogeneous Potentials for Disease Propagation.

Clare Fedele, Gamze Kuser-Abali, Ralph Rossi

|Jun 19, 2024
Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling.

Li-Ying Wu, Su-Ho Park, Haakan Jakobsson

|Sep 11, 2023
Design, optimisation and standardisation of a high-dimensional spectral flow cytometry workflow assessing T-cell immunophenotype in patients with melanoma.

Jack M Edwards, Miles C Andrews, Hayley Burridge

|Mar 11, 2023
UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma.

Gamze Kuser-Abali, Youfang Zhang, Pacman Szeto

Pageof 3

Frequent Collaborators

5 joint publications

Pacman Szeto

3 joint publications

Miles C Andrews

2 joint publications

Dale Jobson

2 joint publications

Graham Mann